Intellia Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

Last updated: 26 Jul 2021

Abstract:

The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.

Status:

Application

Type:

Utility

Filling date:

21 Mar 2018

Issue date:

11 Mar 2021

Full patent description

Patent application document